The PR is encouraging in areas, but it's a PR. The statement about we may review this again later or work with a partner suggests they think they will be in business for a while to come, thus, the NASH results will be positive. But no idea, I won't be surprised either way by Sept. results.
You do not need results to be spectacular. Even a modest fibrosis reduction could translate in massive sales since there is no treatment at the moment not only for liver fibrosis but also for all other organs fibrosis, considering that one third of all global deaths are due to fibrosis
News 
Market Data 
Discover 
